Angelo Gordon & Co’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Angelo Gordon & Co’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,000	Closed	-$6.33M	–	67
2023 Q4	$6.33M	Buy	+20,000	New	+$3.89M	2%	15

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Angelo Gordon & Co's KRTX Position: Q1 2024 in Review

Angelo Gordon & Co sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 20,000 shares — an estimated $6.33M sold.

Angelo Gordon & Co first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $6.33M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Angelo Gordon & Co reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Angelo Gordon & Co sold 20,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.33M.
Angelo Gordon & Co first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Angelo Gordon & Co's Karuna Therapeutics, Inc. Common Stock position peaked at $6.33M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Angelo Gordon & Co's 13F filing for Q1 2024, filed 14 May 2024.